The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for DC Behenna


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer.EBI
Pfizer
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR.EBI
Wuxi Apptec
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBDB
Bayer Aktiengesellschaft
Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitorsBDB
Incyte
Quinoline compounds as modulators of RAGE activity and uses thereofBDB
TBA
Dihydropyrrolopyridine inhibitors of ROR-gammaBDB
Vitae Pharmaceuticals
Conjugate comprising a neurotensin receptor ligand and use thereofBDB
3B Pharmaceuticals